I believe the EU has spent a lot of money on research into EBM, research that can only benefit Arcam. They would not be happy to see Arcam bought out by a non EU company.
The research is nice but at some point Arcam needs to move itself away from Sweden to have a physical location closer to the US or the main EU.A branch won't do ,it needs to be the functional HQ. I would be happier with my investment if it was US based.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.